Financhill
Back

Alnylam Pharmaceuticals, Inc. Stock Predictions

Alnylam Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 38% based on the past 21 years of stock performance.
  • Alnylam Pharmaceuticals, Inc. has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Alnylam Pharmaceuticals, Inc. Stock Undervalued?
    The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $370.00. The Score for ALNY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Alnylam Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Alnylam Pharmaceuticals, Inc. has on average historically risen by 38% based on the past 21 years of stock performance.

Alnylam Pharmaceuticals, Inc. Stock Rating

Sell
45
Alnylam Pharmaceuticals, Inc. (ALNY) is a Sell

Is Alnylam Pharmaceuticals, Inc. overpriced?

  • Alnylam Pharmaceuticals, Inc. has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Alnylam Pharmaceuticals, Inc. Stock Price History

Is ALNY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com

52-Week Data

52-Week High:
495.55
52-Week Low:
205.87

Prediction Charts

Market Cap:
48.9B
Price in USD:
370.00
Volume:
1.9M
Beta:
1.19

Technical Analysis

SMA50:
416.17
SMA100:
437.56
SMA200:
378.49
52-Wk Change:
38.82%

Stock Predictions

  • Is Alnylam Pharmaceuticals, Inc. stock public?
    Yes, Alnylam Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Alnylam Pharmaceuticals, Inc. stock quote today?
    The Alnylam Pharmaceuticals, Inc. stock price is 370.00 USD today.
  • How to buy Alnylam Pharmaceuticals, Inc. stock online?
    You can buy Alnylam Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-31 397.25 397.65 402.44 397.25
Jan-5 397.57 397.83 400.00 383.84
Jan-6 396.23 406.40 409.18 384.42
Jan-7 405.51 422.50 427.05 405.51
Jan-8 420.18 399.40 425.19 393.48
Jan-9 399.40 398.29 409.58 392.56
Jan-12 377.82 370.91 378.61 353.52
Jan-13 369.10 369.96 376.88 366.92
Jan-14 369.95 366.86 371.71 359.95
Jan-15 368.54 359.26 372.82 356.83
Jan-16 362.29 359.27 367.20 355.46
Jan-20 350.70 355.53 355.74 347.77
Jan-21 353.01 365.46 366.00 351.55
Jan-22 365.50 370.00 376.87 363.36

Alnylam Pharmaceuticals, Inc. Earnings

Alnylam Pharmaceuticals, Inc. Earnings Report: Per Share Alnylam Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Alnylam Pharmaceuticals, Inc. Forecast Revenue Growth

Alnylam Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.68 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.44 per share, and an increase next year of $6.61 per share.

* Alnylam Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.